X
Welcome to the
Bioven website
Our focus in on cancer. We are an immuno oncology company with programs in NSCLC and a pipeline in other indications.

LEARN MORE
News Updates
15 Dec 2016 Bioven GETS FDA PHASE III LUNG CANCER STUDY APPROVAL.
21 Oct 2016 Journal of Thoracic Oncology
Bioven GETS FDA PHASE III LUNG CANCER STUDY APPROVAL.